Atherosclerosis

Preclinical Diagnosis and Risk Assessment of Atherosclerosis - At Birth? At Event? When is Best?

Giuseppe Gullace, Hassan Khalaf

Editor's choice

The Role of Non-alcoholic Fatty Liver Disease in Cardiovascular Disease

Sven M Francque, et al.

European Cardiology Review, 2014;9(1):10–5

Latest articles

Guest Editorial: Commentary on the Findings of the GLAGOV Randomized Clinical Trial

Jakub Podolec, Lukasz Niewiara, et al.

US Cardiology Review 2017;11(1):18–9

DOI: .15420/usc.11.1.GE
Optical Coherence Tomography For the Detection of the Vulnerable Plaque

Konstantinos Toutouzas, Antonios Karanasos, Dimitris Tousoulis, et al.

European Cardiology Review 2016;11(2):90–5

DOI: .15420/ecr.2016:29:2
At the Heart of Brain Disorders – Preventing Cognitive Decline and Dementia

Augusto Vicario, Gustavo H. Cerezo, et al.

European Cardiology Review , 2015; 10 (1):60–3

DOI: 10.15420/ecr.2015.10.01.60
Cholesteryl Ester Transfer Protein Inhibitors – Future Soon to be REVEALed

Christopher Huggins, Nicoletta Charolidi, Gillian W Cockerill, et al.

European Cardiology Review . 2015; 10( 1 ) :64–7

DOI: 10.15420/ecr.2015.10.01.64

Media Partners